Healthcare

The healthcare industry is in the midst of a long wave of consolidation.

In addition to the usual motive of attaining critical mass to survive, healthcare companies are especially sensitive to the need for new technologies and access to crossborder markets. Healthcare companies are attractive for international M&A.

With healthcare experts located around the world, Clairfield understands this complicated sector and is perfectly positioned to help clients take advantage of market conditions, focusing on the following segments:

Dental care

Diagnostics

Home health service & residential care

Hospital & clinics

Medical devices/medtech

Medical distributors

Pharmaceuticals

Social services/mental health

Deal spotlight

CLAIRFIELD ADVISES OMAELÄINKLINIKKA AND KORONA INVEST ON THE SALE OF OMAELÄINKLINIKKA TO EVIDENSIA

Korona Invest sold Omaeläinklinikka, a Finnish veterinary chain, to IVC Evidensia, Europe’s largest veterinary care provider. The acquisition strengthens Evidensia’s position as Finland’s largest provider of high-quality veterinary services. Omaeläinklinikka and Evidensia together form the largest veterinary chain in Finland with 50 clinics and over 1,400 employees. Evidensia’s net sales in the previous financial year were approximately EUR 70 million and will increase to approximately EUR 90 million after the transaction.

Deal spotlight

CLAIRFIELD INTERNATIONAL ADVISES PLURADENT GROUP ON SALE TO DEUTSCHE MITTELSTANDSHOLDING

Pluradent Group, Germany’s second largest distributor of dental consumables, dental practice equipment and accompanying technical support services, was acquired by Deutsche Mittelstandsholding, a German investment holding, as part of a debtor in possession insolvency proceeding.

Deal spotlight

RICHARDS PACKAGING INCOME FUND (TSX: RPI.UN) ACQUIRES CLARION MEDICAL TECHNOLOGIES

Richards Packaging Income Fund (TSX: RPI.UN) completed the acquisition of all of the outstanding shares of Clarion Medical Technologies, a Canadian provider of medical, aesthetic, vision care and surgical equipment, and consumables. The purchase price of CAD 64.4 million was financed by a CAD 35.0 million increase to the term credit, a CAD 2.9 million draw down on the revolving credit, CAD 16.0 million of cash on hand and a CAD 10.5 million holdback from the vendors. This purchase price is subject to additional consideration contingent on Clarion’s future earnings.

Deal spotlight & perspectives on public to private transactions

CLAIRFIELD ADVISES NATIONAL VETERINARY CARE
ON SALE TO VETPARTNERS

The deal of the month looks at the public-to-private transaction of ASX-listed National Veterinary Care Ltd, the Australian and New Zealand veterinary services provider, for AU$ 325.5 million. We also comment on takeover premiums and process dynamics. Listed takeover targets cannot always control their public market position, but they can control process better by managing advance  preparation. Clairfield International in Australian partner acted as lead financial advisor to NVC.

Read our latest publications

Recent healthcare transactions

Helsetelefonen, a leading Norwegian telehealth provider, was sold to Volvat.

Korona Invest sold Omaeläinklinikka, a Finnish veterinary chain, to IVC Evidensia, Europe’s largest veterinary care provider.

Dentica24 sp. z o.o., the leading chain of private dental clinics in south of Poland, operating under the DenticaCenter brand, sold a majority stake to Tar Heel Capital, a Poland-based private equity firm.

Berdac, an IT healthcare start-up company, raised EUR 1 million in an investment round from Big Sur Ventures, a venture capital firm, and their former shareholders.

Processing...
Thank you! Your subscription has been confirmed. You'll hear from us soon.
Subscribe to our mailing list
ErrorHere